PU.1 supports proliferation of immature erythroid progenitors

Robert C Fisher1, William B Slayton, Christopher Chien

  • 1Program in Stem Cell Biology and Regenerative Medicine, Shands Cancer Center, Department of Molecular Genetics and Microbiology, Box 100232, Room R4-293, University of Florida, Gainesville, FL 32610, USA. rbfisher@ufl.edu

Leukemia Research
|November 25, 2003
PubMed

Insights

The transcription factor PU.1 is crucial for sustained erythropoiesis (red blood cell production) in adult bone marrow. Loss of PU.1 impairs fetal erythroid progenitor proliferation, highlighting its regulatory role.

Area of Science:

  • Hematology
  • Molecular Biology
  • Developmental Biology

Background:

  • Normal erythropoiesis occurs in PU.1(-/-) embryos.
  • PU.1(-/-) fetal hematopoietic progenitors fail to establish sustained erythropoiesis in adult bone marrow.

Purpose of the Study:

  • To investigate the role of PU.1 in regulating erythroid progenitor proliferation and cytokine responsiveness.
  • To identify PU.1 target genes involved in erythroid lineage development.

Main Methods:

  • Culture of PU.1(-/-) fetal erythroid progenitors with various cytokines (TPO, SCF, EPO, IL-3, GM-CSF).
  • Testing the effect of a constitutively active EPOR variant.
  • Microarray analysis to identify differentially expressed genes.

Main Results:

  • PU.1(-/-) erythroid progenitors showed synergistic expansion with TPO plus SCF, but not EPO plus SCF, IL-3, or GM-CSF.
  • A constitutively active EPOR variant did not correct the EPO defect.
  • Microarray analysis revealed candidate PU.1 target genes affecting cytokine signaling and gene regulation in erythroid cells.

Conclusions:

  • PU.1 plays a critical role in the proliferation of immature erythroid progenitors.
  • PU.1 regulates genes essential for proper erythropoiesis and cytokine responsiveness.

Related Concept Videos

Erythropoiesis01:14

Erythropoiesis

Red blood cells  (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia, and...
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Hematopoiesis01:21

Hematopoiesis

The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
Production of Formed Elements01:34

Production of Formed Elements

Hemangioblasts are multipotent stem cells originating from the mesoderm. They give rise to hematopoietic stem cells (HSCs), which undergo hematopoiesis to produce all the formed elements of blood. This process is regulated by a complex network of hematopoietic growth factors, including transcription factors, growth factors, and cytokines. These factors stimulate the HSCs to divide and differentiate, though some HSCs remain undifferentiated to maintain a self-renewing pool.
Most HSCs commit to...